Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · Real-Time Price · USD
4.375
+0.015 (0.34%)
At close: Aug 21, 2025, 4:00 PM
4.380
+0.005 (0.11%)
After-hours: Aug 21, 2025, 4:00 PM EDT
Vir Biotechnology Market Cap
Vir Biotechnology has a market cap or net worth of $607.76 million as of August 21, 2025. Its market cap has decreased by -48.58% in one year.
Market Cap
607.76M
Enterprise Value
109.53M
1-Year Change
-48.58%
Ranking
Category
Stock Price
$4.38
Market Cap Chart
Since October 11, 2019, Vir Biotechnology's market cap has decreased from $1.53B to $607.76M, a decrease of -60.37%. That is a compound annual growth rate of -14.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2025 | 605.68M | -40.08% |
| Dec 31, 2024 | 1.01B | -25.30% |
| Dec 29, 2023 | 1.35B | -59.83% |
| Dec 30, 2022 | 3.37B | -38.52% |
| Dec 31, 2021 | 5.48B | 60.63% |
| Dec 31, 2020 | 3.41B | 147.35% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 11, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 626.66B |
| Johnson & Johnson | 424.47B |
| AbbVie | 364.92B |
| UnitedHealth Group | 279.39B |
| AstraZeneca | 246.07B |
| Novo Nordisk | 241.43B |
| Novartis AG | 240.40B |
| Abbott Laboratories | 226.73B |